Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142691 |
| CAS No | NA |
| Mol.F. | C11H11N3O4 |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142692 |
| CAS No | NA |
| Mol.F. | C26H23N7O4 |
| Mol.Wt. | 497.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142694 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142695 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142696 |
| CAS No | NA |
| Mol.F. | C24H19N7O4 |
| Mol.Wt. | 469.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142697 |
| CAS No | NA |
| Mol.F. | C25H21N7O4 |
| Mol.Wt. | 483.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142698 |
| CAS No | NA |
| Mol.F. | C23H18N4O5 |
| Mol.Wt. | 430.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142699 |
| CAS No | NA |
| Mol.F. | C23H17N7O4 |
| Mol.Wt. | 455.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142700 |
| CAS No | NA |
| Mol.F. | C10H9N3O4 |
| Mol.Wt. | 235.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142701 |
| CAS No | NA |
| Mol.F. | C32H31N7O7 |
| Mol.Wt. | 625.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142702 |
| CAS No | NA |
| Mol.F. | C22H15N7O4 |
| Mol.Wt. | 441.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142703 |
| CAS No | NA |
| Mol.F. | C8H6ClN3O3S |
| Mol.Wt. | 259.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142704 |
| CAS No | NA |
| Mol.F. | C7H4ClN3O4S |
| Mol.Wt. | 261.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142705 |
| CAS No | NA |
| Mol.F. | C8H9N3O4S |
| Mol.Wt. | 243.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142706 |
| CAS No | NA |
| Mol.F. | C8H7ClN2O5S |
| Mol.Wt. | 278.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142707 |
| CAS No | NA |
| Mol.F. | C15H21N3O2 |
| Mol.Wt. | 275.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |